Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene

Paul J. Isackson, Heather Bujnicki, Cary Harding, Georgirene D. Vladutiu

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We have examined two Caucasian brothers with myoadenylate deaminase (AMPD) deficiency who presented with exercise intolerance and muscle cramps. Allele-specific PCR amplification assays demonstrated that the common Q12X (C34T) and P48L (C143T) mutations were not found within their AMPD1 genes. Further analysis revealed that both brothers were compound heterozygotes for a previously reported K287I (A860T) mutation in exon 7 and a novel deletion within intron 2 (IVS2-(4-7)delCTTT). The intronic deletion appears to affect the splicing machinery since characterization of AMPD1 mRNA from skeletal muscle of one brother identified multiple alternatively spliced transcripts resulting in multiple deletions in exon 3, the complete deletion of either exon 3 or exons 3 and 4, and the activation of a cryptic splice site that resulted in an insertion at the 5′ end of exon 4. The predominant transcript contains a 51 base deletion at the 5′ end of exon 3 that is predicted to produce a functional form of AMPD containing a 17-amino acid residue deletion within its N-terminal region. Analysis of 137 Caucasian normal control patients determined that the K287I mutation is relatively frequent (5.1% carrier frequency), whereas the IVS2-(4-7)delCTTT mutation is rare and not present in 274 chromosomes.

Original languageEnglish (US)
Pages (from-to)250-256
Number of pages7
JournalMolecular Genetics and Metabolism
Volume86
Issue number1-2
DOIs
StatePublished - Sep 2005

Fingerprint

AMP Deaminase
Alternative Splicing
Exons
Genes
Mutation
Siblings
Muscle
Muscle Cramp
RNA Splice Sites
Heterozygote
Chromosomes
Introns
Machinery
Amplification
Assays
Skeletal Muscle
Chemical activation
Alleles
Exercise
Amino Acids

Keywords

  • Alternative splicing
  • Compound heterozygosity
  • Metabolic myopathy
  • Myoadenylate deaminase deficiency
  • Splice site mutation

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene. / Isackson, Paul J.; Bujnicki, Heather; Harding, Cary; Vladutiu, Georgirene D.

In: Molecular Genetics and Metabolism, Vol. 86, No. 1-2, 09.2005, p. 250-256.

Research output: Contribution to journalArticle

Isackson, Paul J. ; Bujnicki, Heather ; Harding, Cary ; Vladutiu, Georgirene D. / Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene. In: Molecular Genetics and Metabolism. 2005 ; Vol. 86, No. 1-2. pp. 250-256.
@article{48509d38661b4be6b5e27eb703af5276,
title = "Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene",
abstract = "We have examined two Caucasian brothers with myoadenylate deaminase (AMPD) deficiency who presented with exercise intolerance and muscle cramps. Allele-specific PCR amplification assays demonstrated that the common Q12X (C34T) and P48L (C143T) mutations were not found within their AMPD1 genes. Further analysis revealed that both brothers were compound heterozygotes for a previously reported K287I (A860T) mutation in exon 7 and a novel deletion within intron 2 (IVS2-(4-7)delCTTT). The intronic deletion appears to affect the splicing machinery since characterization of AMPD1 mRNA from skeletal muscle of one brother identified multiple alternatively spliced transcripts resulting in multiple deletions in exon 3, the complete deletion of either exon 3 or exons 3 and 4, and the activation of a cryptic splice site that resulted in an insertion at the 5′ end of exon 4. The predominant transcript contains a 51 base deletion at the 5′ end of exon 3 that is predicted to produce a functional form of AMPD containing a 17-amino acid residue deletion within its N-terminal region. Analysis of 137 Caucasian normal control patients determined that the K287I mutation is relatively frequent (5.1{\%} carrier frequency), whereas the IVS2-(4-7)delCTTT mutation is rare and not present in 274 chromosomes.",
keywords = "Alternative splicing, Compound heterozygosity, Metabolic myopathy, Myoadenylate deaminase deficiency, Splice site mutation",
author = "Isackson, {Paul J.} and Heather Bujnicki and Cary Harding and Vladutiu, {Georgirene D.}",
year = "2005",
month = "9",
doi = "10.1016/j.ymgme.2005.06.002",
language = "English (US)",
volume = "86",
pages = "250--256",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "1-2",

}

TY - JOUR

T1 - Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene

AU - Isackson, Paul J.

AU - Bujnicki, Heather

AU - Harding, Cary

AU - Vladutiu, Georgirene D.

PY - 2005/9

Y1 - 2005/9

N2 - We have examined two Caucasian brothers with myoadenylate deaminase (AMPD) deficiency who presented with exercise intolerance and muscle cramps. Allele-specific PCR amplification assays demonstrated that the common Q12X (C34T) and P48L (C143T) mutations were not found within their AMPD1 genes. Further analysis revealed that both brothers were compound heterozygotes for a previously reported K287I (A860T) mutation in exon 7 and a novel deletion within intron 2 (IVS2-(4-7)delCTTT). The intronic deletion appears to affect the splicing machinery since characterization of AMPD1 mRNA from skeletal muscle of one brother identified multiple alternatively spliced transcripts resulting in multiple deletions in exon 3, the complete deletion of either exon 3 or exons 3 and 4, and the activation of a cryptic splice site that resulted in an insertion at the 5′ end of exon 4. The predominant transcript contains a 51 base deletion at the 5′ end of exon 3 that is predicted to produce a functional form of AMPD containing a 17-amino acid residue deletion within its N-terminal region. Analysis of 137 Caucasian normal control patients determined that the K287I mutation is relatively frequent (5.1% carrier frequency), whereas the IVS2-(4-7)delCTTT mutation is rare and not present in 274 chromosomes.

AB - We have examined two Caucasian brothers with myoadenylate deaminase (AMPD) deficiency who presented with exercise intolerance and muscle cramps. Allele-specific PCR amplification assays demonstrated that the common Q12X (C34T) and P48L (C143T) mutations were not found within their AMPD1 genes. Further analysis revealed that both brothers were compound heterozygotes for a previously reported K287I (A860T) mutation in exon 7 and a novel deletion within intron 2 (IVS2-(4-7)delCTTT). The intronic deletion appears to affect the splicing machinery since characterization of AMPD1 mRNA from skeletal muscle of one brother identified multiple alternatively spliced transcripts resulting in multiple deletions in exon 3, the complete deletion of either exon 3 or exons 3 and 4, and the activation of a cryptic splice site that resulted in an insertion at the 5′ end of exon 4. The predominant transcript contains a 51 base deletion at the 5′ end of exon 3 that is predicted to produce a functional form of AMPD containing a 17-amino acid residue deletion within its N-terminal region. Analysis of 137 Caucasian normal control patients determined that the K287I mutation is relatively frequent (5.1% carrier frequency), whereas the IVS2-(4-7)delCTTT mutation is rare and not present in 274 chromosomes.

KW - Alternative splicing

KW - Compound heterozygosity

KW - Metabolic myopathy

KW - Myoadenylate deaminase deficiency

KW - Splice site mutation

UR - http://www.scopus.com/inward/record.url?scp=26244451261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26244451261&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2005.06.002

DO - 10.1016/j.ymgme.2005.06.002

M3 - Article

C2 - 16040263

AN - SCOPUS:26244451261

VL - 86

SP - 250

EP - 256

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 1-2

ER -